Pathology professor named first KGH Research Chair
Queen's Pathology and Molecular Medicine professor Jeremy Squire has been appointed Kingston General Hospital's first-ever Research Chair in Molecular Pathology.
As research chair, Dr. Squire will continue his internationally renowned research, currently focused in prostate cancer and osteosarcoma, while fostering and developing interdisciplinary research collaborations at KGH and across Kingston's academic health sciences centre, affiliated with the university.
“Close interactions between basic scientists and clinicians from various disciplines such as pathology, oncology and genetics help create a very dynamic environment,” explains Dr. Squire. “By bringing these multidisciplinary teams together, we can apply our research discoveries directly to patients, where it will have the greatest impact and opportunity for further advances.”
Dr. Squire will also serve as Director of Translational Laboratory Research with the National Cancer Institute of Canada's Clinical Trials Group (NCIC CTG) based at Queen's Cancer Research Institute. In this role he will facilitate all research projects across the country, as well as help lead the establishment of future strategic directions related to translational research – the application of basic research in a clinical setting. Working closely with Janet Dancey, who recently joined NCIC CTG as Director of Translational Clinical Research, Dr. Squire will help promote and support implementation and development of research findings in clinical practice.
Considered one of the foremost cytogeneticists in the world, Dr. Squire has spent more than 25 years as a research scientist and, most recently, has held senior positions with Princess Margaret Hospital and the University Health Network in Toronto. As a cytogeneticist, Dr. Squire looks for genetic abnormalities that might help uncover the onset, cause and progression of cancer as well the most appropriate and effective forms of treatment or therapy.
The establishment of a research chair, which was funded in part by an endowment governed by the KGH Foundation, is a tremendous boost to the hospital's teaching and research mandate, says Iain Young, head of the Department of Pathology and Molecular Medicine at KGH and at Queen's. “The opportunity to recruit an international leader in translational cancer research like Dr. Squire is a real coup for KGH and we look forward to what he will bring to our academic health sciences centre.”